Brind.

HealthDay News reported on the operational status of NIAID, while Jeremy Konyndyk commented on its institutional decline.

1 report, 1 independent Updated May 28

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

National Institute of Allergy and Infectious Diseases Jeremy Konyndyk Jeffery Taubenberger

Keep exploring

The entities involved

National Institute of Allergy and Infectious Diseases
US research institute for the treatment and prevention of infectious diseases
- A company has entered into a non-clinical evaluation agreement with NIAID, partnering with AFRRI on protocol design that meets FDA Animal Rule criteria.Fri 13:17
- NIAID funded a study at AFRRI to evaluate the therapeutic efficacy of a company's product.Fri 13:17
Jeremy Konyndyk
president of Refugees International

Nothing else this week.
Jeffery Taubenberger
American virologist

Nothing else this week.

Related events

The new event discusses the relationship between NIH and NIAID, confirms Anthony Fauci's former role as NIAID director, and notes public confidence issues regarding health organizations and figures like Fauci and Robert F. Kennedy Jr.Sep 9

Coverage

Newest first; wire copies grouped

May 28neurologyadvisor.com